This is what concerns me also, as much as Bruce is a smart and accomplished dr, the relationship path he has chosen is questionable. It could be that cytodyn did not treat him well and this is basically a personality problem. However I think many want current mgmt and Bruce to be part of the company, this might sound like some sort of dream team but it clearly would be a disaster. Bruce aligned with 13d, we can only look at this as a current mgmt vs 13d mgmt, no picking and choosing.
I think we should also look at what is needed mostly, and that is a great FDA relationship and trial data that shows how great leronlimab is for all indications it is theorized to be helpful. Only new people that can offer help in those areas are needed. A big ego likely will not work well with the FDA, Bruce my know is stuff but if the fda does not want his path, how will he navigate that?
It is always better to be confident in your ability to navigate difficulties, rather than think you do everything perfect so there will be no difficulties. Nader, for what ever you think of him, does manage reality and simply moves forward. We can claim it was his mistakes that created difficulties but that would also be thinking that there would be no difficulties getting a trial to approval. Even large pharma has difficulties, the difference is they can afford to walk away. Cytodyn has to face them and move forward.
I think we should also look at what is needed mostly, and that is a great FDA relationship and trial data that shows how great leronlimab is for all indications it is theorized to be helpful. Only new people that can offer help in those areas are needed. A big ego likely will not work well with the FDA, Bruce my know is stuff but if the fda does not want his path, how will he navigate that?
It is always better to be confident in your ability to navigate difficulties, rather than think you do everything perfect so there will be no difficulties. Nader, for what ever you think of him, does manage reality and simply moves forward. We can claim it was his mistakes that created difficulties but that would also be thinking that there would be no difficulties getting a trial to approval. Even large pharma has difficulties, the difference is they can afford to walk away. Cytodyn has to face them and move forward.
14
